Announcements Trials
Browse Landscape

Phase

Phase 2 287Phase 3 181Phase NA 40Phase 1/2 22Phase 1 21Phase 2/3 10Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 225INDUSTRY 214FED 5NETWORK 2UNKNOWN 1OTHER_GOV 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine 1Docetaxel 1Carboplatin 123-valent pneumococcal capsular polysaccharide vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × NETWORK × Has results × Clear all
NCT02447718 2022-06-24

Vaccinating Children After Chemotherapy

Canadian Immunization Research Network

Phase 4 Completed
156 enrolled 19 charts
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00883675 2013-12-18

Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

Maestro Clinical, Inc.

Phase 4 Completed
133 enrolled 8 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡